Daily Archives: April 5, 2016

#ACC16: Rate versus rhythm control equally effective for atrial fibrillation after cardiac surgery

5 Apr, 2016 | 14:31h | UTC

Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery – New England Journal of Medicine (free)

Rhythm vs Rate Control: A Toss-up for Postoperative AF – Medscape commentary (free registration required)

---

#ACC16: HOPE-3 Study. 100 intermediate-risk persons would have to be treated with statins for 5 years to prevent 1 cardiovascular event

5 Apr, 2016 | 14:34h | UTC

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease – New England Journal of Medicine (free)

Editorial: More HOPE for Prevention with Statins – New England Journal of Medicine (free)

HOPE-3: Does Primary Cardiovascular Prevention Benefit People at Intermediate Risk? – NEJM Journal Watch commentary (free)

Statin treatment reduced cardiovascular events more than hypertension drugs in intermediate-risk patients, study finds – ACP Internist Weekly Review (free)

HOPE-3: Statins Lower CV Events in Intermediate-CHD-Risk Patients – Medscape commentary (free registration required)

---

#ACC16: Transcatheter aortic-valve replacement (TAVR) noninferior to surgery in intermediate-risk patients

5 Apr, 2016 | 14:30h | UTC

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients – New England Journal of Medicine (free)

Editorial: Will TAVR Become the Predominant Method for Treating Severe Aortic Stenosis? – New England Journal of Medicine (free)

Quick Take Video Summary: Aortic-Valve Replacement – New England Journal of Medicine (free)

How Does TAVR Fare in Intermediate-Risk Patients? – NEJM Journal Watch commentary (free)

PARTNER 2 Backs TAVR Use in Intermediate-Risk Patients With Severe Aortic Stenosis – Medscape commentary (free registration required)

---